El fármaco rentosertib, creado con ayuda de una IA para tratar la fibrosis pulmonar idiopática, muestra un efecto prometedor en seis relojes biológicos que miden la edad del cuerpo

Insilico Medicine's AI-discovered drug rentosertib enters Phase III trials for lung fibrosis, targeting cellular senescence with implications for

Six proteomic ageing clocks agreed patients on Insilico’s AI-designed lung drug looked younger. The authors cannot yet rule out the treated lung.